内在的大脑功能连接预测了早期帕金森病患者治疗相关的运动并发症
Rosa De Micco1, Federica Di Nardo1, Mattia Siciliano1,2
1Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Journal of neurology
|October 9, 2023
概括
早期帕金森病 (PD) 的大脑网络差异预测运动并发症. 基线时的特定功能连接 (FC) 变化可以识别随着时间的推移,患有这些与治疗相关问题的风险更高的患者.
科学领域:
- 神经成像是一种神经成像.
- 帕金森病研究 帕金森病研究
- 大脑网络分析 脑网络分析
背景情况:
- 运动并发症是帕金森病 (PD) 的一个渐进的挑战.
- 早期识别容易出现这些并发症的患者对于管理至关重要.
研究的目的:
- 为了研究内在大脑网络中的基线功能连接 (FC).
- 在4年的时间内,在早期帕金森病 (PD) 患者中确定与治疗相关的运动并发症的预测因素.
主要方法:
- 分析了88名从未服用过药物的PD患者和20名健康对照者的基线MRI扫描.
- 利用独立组件分析来评估静态网络中的FC.
- 使用考克斯回归来确定四年随访时运动并发症的基线预测因素.
主要成果:
- 与没有发生运动并发症 (PD-no-Compl) 的患者相比,在基线时,患有运动并发症 (PD-Compl) 的PD患者表现出额头网络FC增加和默认模式网络连接性降低.
- PD-Compl患者保持了与对照组相似的感觉运动FC.
- 基线FC差异独立预测了运动并发症的发展.
结论:
- 特定的基线FC变化可以标志着早期帕金森病 (PD) 患者有较高的运动并发症风险.
- 这些发现表明,前额和前额回路存在固有漏洞.
- FC模式可能作为未来帕金森病 (PD) 临床试验的潜在生物标志物.
相关概念视频
Parkinson's Disease: Treatment
283
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
283
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Parkinson's Disease: Overview
579
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
579


